Stockholm-based RaySearch Laboratories announces that a sales agent agreement has been signed with Canon Medical Systems USA, enabling RaySearch America’s salesforce to promote Canon Medical’s Aquilion Large Bore CT and Celesteion PET/CT products. Together, the companies will bring their integrated radiation oncology portfolio to more U.S. customers to further enhance care for cancer patients.
Since 2018, Canon Medical and RaySearch have collaborated to offer Canon Medical’s imaging systems and advanced visualization solutions with RaySearch’s treatment planning system, RayStation, and oncology information system, RayCare. RayStation’s full suite of technologies can be paired with these imaging systems, though customers can also select the stand-alone RayStation Simulation package to drive virtual simulations. Together, the companies have been able to deliver accuracy- and workflow-focused solutions to customers and patients and have gained positive traction in the market.
“Over the last two years, our partnership with RaySearch has helped us deliver on our Made for Life philosophy by providing a comprehensive oncology solution that has brought together the tools for optimal treatment planning for our customers,” says Yuji Hamada, president and CEO, Canon Medical Systems, USA. “In this new phase of our collaboration, we look forward to bringing the benefits of our combined solution to even more customers and patients.”
Johan Löf, founder and CEO, RaySearch, adds, “Canon Medical is a world leader in advanced imaging and visualization systems, and we share a view of the potential of technology to drive innovation and development in oncology. Our products are an outstanding complement to each other, providing cancer centers with a powerful platform for radiation oncology.”